Bovie Medical (NYSE:BVX), fresh from the sale of its core electro-cautery business, saw its share price take a hit today after it updated its outlook for the rest of the year. Last month Bovie dealt its core business, including the Bovie brand, to Symmetry Surgical for $97 million. The all-cash sale augured a pivot for Clearwater, Fla.-based Bovie toward the cosmetic surgery […]
Bovie Medical closes $97m sale of core electro-cautery biz to Symmetry Surgical
Bovie Medical (NYSE:BVX) said today it closed the $97 million sale of its core electro-cautery business, including the Bovie brand, to Symmetry Surgical. The all-cash sale comes as Clearwater, Fla.-based Bovie looks to pivot toward the cosmetic surgery market, and includes transition services, patent licensing, disposables supply and generator manufacturing agreements. The deal also includes terms […]
Bovie Medical shares rise on Q1 sales Beat, closed enrollment of cosmetic J-Plasma IDE study
Shares in Bovie Medical (NYSE:BVX) rose today after the medical device maker beat sales expectations on Wall Street with its first quarter earnings release and announced that it closed enrollment of an FDA investigational device exemption study of its J-Plasma tech seeking a new cosmetic indication. The Clearwater, Fla.-based company posted losses of $935,000, or 3¢ […]
Bovie Medical launches Renuvion cosmetic surgery J-Plasma brand
Bovie Medical (NYSE:BVX) said yesterday it launched the Renuvion brand of cosmetic surgery devices using its J-Plasma technology. Through the newly launched brand, the Clearwater, Fla.-based company said it will sell devices powered by the J-Plasma technology specifically for the cosmetic surgery market. The J-Plasma device is a plasma-based cutter and coagulator that uses helium ionization […]
Bovie Medical launches IDE J-Plasma dermal skin resurfacing study
Bovie Medical (NYSE:BVX) said today it launched an FDA investigational device exemption clinical study of its J-Plasma surgical cutter, looking to explore the use of the device in dermal skin resurfacing. The first patient in the trial was enrolled by Dr. J. Holcomb at Sarasota, Fla.’s Institute for Integrated Aesthetics. The J-Plasma device is a plasma-based cutter […]
Zimmer Biomet lures Medtronic vet Hanson to CEO spot | Personnel Moves December 19, 2017
Zimmer Biomet (NYSE:ZBH) said today it tapped former Medtronic (NYSE:MDT) exec VP Bryan Hanson as its new prez and CEO, replacing interim CEO Daniel Florin who will continue on as CFO and senior VP. A 20-year veteran of medical devices, Hanson operated most recently as group president of Fridley, Minn.-based Medtronic’s approximately $9 billion minimally invasive […]
Spinal Elements lifts former COO Blain to the corner office | Personnel Moves November 30, 2017
Spinal Elements, previously known as Amendia, said this week it is lifting co-founder and current prez & COO Jason Blain to the position of prez & CEO, effective immediately. Prior to coming on to co-found Spinal Elements, Blain served in various roles with medtech companies Smith & Nephew (NYSE:SNN), Alphatec (NSDQ:ATEC) and NuVasive Inc. (NSDQ:NUVA). Blain is replacing […]
Bovie Medical tanks after failing to renew J-Plasma deal with Hologic
Bovie Medical (NYSE:BVX) saw shares plummet this week after it announced it did not extend the sales channel partnership with Hologic (NSDQ:HOLX) for its J-Plasma product, which is set to expire at the end of February. Bovie Medical’s J-Plasma is a plasma-based cutter and coagulator that uses helium ionization to produce a focused beam of ionized gas over […]
Bovie Medical inks distro deal for PlazXact Ablator
Bovie Medical (NYSE:BVX) said today it inked a global sales channel partnership deal with ConMed (NSDQ:CNMD) for its PlazXact Ablator. As part of the deal, Utica, N.Y.-based ConMed’s PlazXact Ablator will be marketed as the UltrAblator Bipolar series, effective March 2017, according to Bovie Medical. “Partnering with a company of ConMed’s reputation builds on Bovie’s strategy to scale […]
Bovie Medical closes $6m offering
Bovie Medical (NYSE:BVX) today closed a $6 million funding round, floating 1.63 million shares of stock at $4 per share. The round also included a secondary offering of 1.63 million shares made by certain stockholders of the company, Clearwater, Fla.-based Bovie Medical said in an SEC filing. Net proceeds, after deducting discounts, commissions and expenses from the primary […]
Bovie Medical prices $12m round
Bovie Medical (NYSE:BVX) today released pricing for an upcoming offering, looking to bring in $12 million with funds slated to support expanding sales and marketing and R&D. The Clearwater, Fla.-based company said it is looking to float 3 million shares of its common stock at $4 per share. A total of 1.5 million of those shares […]
- 1
- 2
- 3
- 4
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+